Hepatic and hematological complications following ecstasy usage

O. Shibolet*, Y. Kalish, S. Gillis, Y. Ilan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


"Ecstasy" (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.

Original languageEnglish
Pages (from-to)911-914, 991
Issue number10
StatePublished - Oct 2001
Externally publishedYes


Dive into the research topics of 'Hepatic and hematological complications following ecstasy usage'. Together they form a unique fingerprint.

Cite this